SGLT2 i dapagliflozin reduces NF-κB expression in heart and kidneys of preclinical models exposed to doxorubicin through MYd-88 and NLRP3 pathways-MedSci.cn

SGLT2 i dapagliflozin reduces NF-κB expression in heart and kidneys of preclinical models exposed to doxorubicin through MYd-88 and NLRP3 pathways

Maurea, N; Bisceglia, I; Iovine, M; Paccone, A; Palma, G; Bruzzese, F; Luciano, A; Florio, F; Marino, FZ; Franco, R; Quagliariello, V

ANNALS OF ONCOLOGY, 2023; 34 (): S1175

科室
- - 订阅+
  - 更多科室
工具
服务